Investor Relations (IR) Questions: Astex Pharmaceuticals ASTX
Click here to return to the biotech IRQ Index
Answers received: February 2013
1) When is the last time ASTX raised cash through an offering (diluted)?
2004
2) How much cash (not cash equivalents) does ASTX have?
At September 30, 2012, Astex had ~$130M in cash and marketable securities.
3) What and approximately when is the next known catalyst?
1Q2013 Earnings Call
2Q2013 AACR data on all products (preclinical)
2Q2013: SGI-110 – initial phase II data at ASCO
4) What is ASTX's quarterly cash burn?
ASTX was cash flow positive through 3Q2012, and their YE2012 financials will be available shortly.
Currently, ASTX projects net cash burn from a cash flow perspective of ($10M) for 2013, which may be revised when the year-end financials 2012 are presented in 1Q2013.
5) Does ASTX have an existing line of credit and if so how much can they draw against it?
ASTX has a $200M shelf registration that has been active and unused for over 5 years. They have no line of credit.
1) When is the last time ASTX raised cash through an offering (diluted)?
2004
2) How much cash (not cash equivalents) does ASTX have?
At September 30, 2012, Astex had ~$130M in cash and marketable securities.
3) What and approximately when is the next known catalyst?
1Q2013 Earnings Call
2Q2013 AACR data on all products (preclinical)
2Q2013: SGI-110 – initial phase II data at ASCO
4) What is ASTX's quarterly cash burn?
ASTX was cash flow positive through 3Q2012, and their YE2012 financials will be available shortly.
Currently, ASTX projects net cash burn from a cash flow perspective of ($10M) for 2013, which may be revised when the year-end financials 2012 are presented in 1Q2013.
5) Does ASTX have an existing line of credit and if so how much can they draw against it?
ASTX has a $200M shelf registration that has been active and unused for over 5 years. They have no line of credit.
